102940 — Kolon Life Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual cashflow statement for Kolon Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-92,323	-43,195	-1,375	2,133	-30,726
Depreciation
Amortisation
Non-Cash Items	67,740	16,327	8,346	4,939	12,620
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-9,636	6,532	-34,458	-37,393	-15,590
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-20,181	-7,307	-16,187	-20,854	-24,866
Capital Expenditures	-30,785	-2,743	-4,413	-6,308	-10,237
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	11,172	21,780	2,158	371	3,211
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-19,613	19,037	-2,255	-5,937	-7,026
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	13,014	-2,379	30,949	5,458	32,889
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-26,758	9,087	12,799	-21,429	1,190